Past Events

Parasitic Infection 2016: 28th – 30th June 2016



In an academic setting, this event will focus on the current research into parasitic infection and disease.

Agend    Abstract book

Over three days, this international summit will cover recent research and developments relating to diagnosis, treatment and drug design. Parasitic infections including malaria and neglected diseases, such as trypanosomiasis, will be discussed in detail, as well as discussion about methods of eradication.


  • The deadline for abstract submissions for oral presentation is 10th April 2016.
  • The early registration deadline is 20th May 2016
  • The deadline for abstract submissions for poster presentation is 14th June 2016

This event has now passed

Our follow up event can be viewed at

Who Should Attend: This event is suited to anyone with an academic or professional interest in parasitic infection and its research; including researchers, senior scientists, postgraduate students, clinicians, pharmacologists, and those who work in research and development of pharmaceuticals and related technology.

Talks Include

Talk TitleSpeakerAffiliationCountry
Natural products as leads to new antiprotozoal drugsDr Colin WrightBradford School of PharmacyUnited Kingdom
Long-term artemisinin pressure in falciparum Malaria induces multidrug toleranceDr Françoise Benoit-VicalNational Institute of Health and Medical ResearchFrance
When peptide chemistry meets antimalarial drug developmentDr. Paula GomesUniversity of PortoPortugal
Natural Products in Drug Developmentand Environmental Control of MalariaDr Joseph M. AgbedahunsiObafemi Awolowo UniversityNigeria
Recent Progress in Structure-Guided Drug Discovery for Parasitic DiseasesDr Raymond HuiUniversity of TorontoCanada
Epidemiological profile of cutaneous leishmaniasis in the province of Taza (Morocco)
El-houcine SebbarThe Military Hospital of Instruction Med VMorocco
New tools for Malaria InterventionDr David W. Wright, Vanderbilt UniversityUnited States
Can the parasitic worm product ES-62 be used to develop drugs for treating allergic and autoimmune diseases?
Professor William HarnettUniversity of StrathclydeUnited Kingdom
Glimpse of index of infectious parasites incidence in Nigeria: Enugu study
Emmanuel Chike AmadiEnugu State University of Science and TechnologyNigeria
Control of arthropod-borne infectious diseases – extrapolating from the known to the unknownProfessor Andrew Taylor-RobinsonCQ UniversityAustralia
Fluorescence In Situ Hybridization (FISH) for diagnosing malaria in endemic areasProfessor Ranjan RamasamyAnglia Ruskin UniversityUnited Kingdom
Detection of Opisthorchis viverrini Infection in the Rural Community of thailand by Using Korat-Ov Verbal Screening Test and Mini Parasep SF Concentration Technique
Dr. Natthawut Kaewpitoon, Suranaree University of TechnologyThailand
Conditional inactivation of the Interleukin-1 receptor gene reveals an important role for cytokine regulation during Trichuris muris infection in mice.
Werner MüllerUniversity of ManchesterUnited Kingdom
New biomarkers and interventions for severe and cerebral MalariaDr. Kevin C. KainToronto General HospitalCanada
TBCDr Yee Ling Lau University of MalayaMalaysia
Point-of-care device for malaria diagnosis and drug resistance statusProfessor Sanjeev KrishnaUniversity of LondonUnited Kingdom
An integrated approach to control intestinal helminth infectionsDr. Giovanna RasoUniversity of BaselSwitzerland
NANOHAT: developing a safer and more effective sleeping sickness drug.Dr. Sarah A. ThomasKing's College LondonUnited States
Establishment of chronic infection in malaria involves a novel method of immune evasion
Dr. Adam James ReidWellcome Trust Sanger InstituteUnited Kingdom
Control of schistosomiasis and soil-transmitted helminthiasis: A COUNTDOWN to WHO 2020 Roadmap targets for neglected tropical diseasesProfessor Russell StothardLiverpool School of Tropical MedicineUnited Kingdom
Differential local immune response of the human placanta against the protozoan parasites Trypanosoma cruzi and Toxoplasma gondiiProfessor Ulrike KemmerlingUniversidad de ChileChile
Acanthamoeba corneal infectionProfessor John Dart,University College LondonUnited Kingdom
DNA repair in Trypanosoma cruzi: A mechanism of survival and persistence in its hostsProfessor Norbel GalantiUniversity of ChileChile
Plasmodium knowlesi malaria Dr. Janet Cox-SinghUniversity of St AndrewsUnited Kingdom
A chemical drug delivery approach to improve antimalarial activityDr. Francisca LopesUniversidade de LisboaPortugal
Discovery of secondary metabolites for treatment of malaria disease on different stage of Plasmodium life cycleDr. Giuseppina ChianeseUniversity of Naples "Federico II"Italy
The parasitic worm immunomodulator ES-62 resets the effector: regulatory B cell balance in inflammatory diseaseProfessor Margaret HarnettUniversity of GlasgowUnited Kingdom
The role of mast cell in malaria infectionDr. Panop WilainamMahidol UniversityThailand
Modeling Importations and Exportations of Infectious Diseases via TravelersDr. Eduardo MassadUniversity of Sao PauloBrazil
Chemical genetics approach to study the role of essential protein kinases in malaria parasite.Dr Mahmood AlamMRC LeicesterUnited Kingdom
Exploration of natural compounds to treat drug resistant malariaDr Prakash Udhawdas Tahiliani,Prime Ever Ayurvedic Research LaboratoriesIndia
Fake Medicines: How can we know?Dr. Harparkash KaurLSHTMUnited Kingdom

Advisory Board Members

Professor Ranjan Ramasamy Anglia Ruskin University, Cambridge United Kingdom
Dr. Niroshini Nirmalan University of Salford United States
Dr Henk D.F.H. Schallig Royal Tropical Institute / Koninklijk Institut voor de Tropen – Parasitology Unit, KIT Biomedical Research Netherlands
Professor Andrew Taylor-Robinson CQ University Australia
Dr Emmanuel Chike Amadi Enugu State University of Science and Technology Nigeria
Assistant Professor Catherine Demailly-Mullie Universite de Picardie Jules Verne France

Parasitic Infection 2016 has an open abstract session:  Abstracts can be submitted on any subject related to parasitic infection and disease.

CPD Credits

Related Past Agendas



Email:? enquiries [@]

Phone:?(+44) 020 3807 3712

Abstract and Poster Presentations

All abstracts accepted for oral presentation are also automatically accepted for poster presentation


Cancellation Policy

Join the conversation

Related past events




This is a closed event

Only participants who have registered are licensed to attend this event. This is for the protection and peace of mind of our speakers who are presenting unpublished work. We ask our participants not to share their screen with people who are not registered for the event and will fine those who do.

Latest Euroscicon Tweets

Error: You currently have access to a subset of Twitter API v2 endpoints and limited v1.1 endpoints (e.g. media post, oauth) only. If you need access to this endpoint, you may need a different access level. You can learn more here: